Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-03-04

Clinical Trial Update: 1-Octanol to Treat Essential Tremor [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating 1-octanol for essential tremor has completed. The study was sponsored by the National Institute of Neurological Disorders an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 1-Octanol (octan-1-ol)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Essential Tremor | Phase 1 | Status: COMPLETED